Reduced Concussion Symptom Burden in Early Adolescent Athletes Using a Head–Neck Cooling Device
Authors:
- Matthew A. SmithMSMatthew A. Smith
- Neil L. MS McNinchNMNeil L. MS McNinch
- Danielle Macpr ChaneyDCDanielle Macpr Chaney
- Lisa ShauverLSLisa Shauver
- Tamara Aprn MurrayTMTamara Aprn Murray
- Peyton Bsph KlinePKPeyton Bsph Kline
- Alexandria LesakALAlexandria Lesak
- Lea Franco-MacKendrickLFLea Franco-MacKendrick
- Lora ScottLSLora Scott
- Kelsey Md LoganKLKelsey Md Logan
- Ingrid K. IchescoIIIngrid K. Ichesco
- Christopher LiebigCLChristopher Liebig
Open Access
- 5 January 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Journal of Sport Medicine
- Vol. 34 (3) , 247-255
Abstract
Objective: To determine whether an investigational head–neck cooling device, Pro2cool, can better reduce symptom severity compared with standard postconcussion care in early adolescent athletes after a sports-related concussion. Design: Prospective, longitudinal, randomized trial design conducted over a 28-day period. Setting: Six pediatric medical centers in Ohio and Michigan. Participants: The study enrolled 167 male and female 12- to 19-year-old athletes who experienced a sports-related concussion within 8 days of study enrollment and registering a Sports Concussion Assessment Tool 5 (SCAT5) composite score >7. Interventions: Pro2cool, an investigational head–neck cooling therapy device, was applied at 2 postinjury time points compared with postconcussion standard of care only. Main Outcome Measures: Baseline SCAT5 composite symptom severity scores were determined for all subjects. Sports Concussion Assessment Tool 5 scores for concussed athletes receiving cooling treatment were analyzed across 6 independent postenrollment time points compared with subjects who did not receive cooling therapy and only standard care. Adverse reactions and participate demographics were also compared. Results: Athletes who received Pro2cool cooling therapy (n = 79) experienced a 14.4% greater reduction in SCAT5 symptom severity scores at the initial visit posttreatment, a 25.5% greater reduction at the 72-hour visit posttreatment, and a 3.4% greater reduction at the 10-day visit compared with subjects receiving only standard care (n = 88). Overall, 36 adverse events (increased blood pressure, decreased pulse, and dizziness) were reported, with 13 events associated with the device, of which 3 were classified as moderate in severity. Conclusions: This study demonstrates the efficacy and safety of head and neck cooling for the management of concussion symptoms in adolescent athletes of an age group for which little to no prior data are available.Keywords
This publication has 33 references indexed in Scilit:
- Emergence of cognitive deficits after mild traumatic brain injury due to hyperthermiaExperimental Neurology, 2015
- The New Neurometabolic Cascade of ConcussionNeurosurgery, 2014
- Therapeutic Hypothermia and the Risk of InfectionCritical Care Medicine, 2014
- Head and Neck Cooling Decreases Tympanic and Skin Temperature, But Significantly Increases Blood PressureStroke, 2012
- Mild Hyperthermia Worsens the Neuropathological Damage Associated with Mild Traumatic Brain Injury in RatsJournal of Neurotrauma, 2012
- Surface cooling for induction of mild hypothermia in conscious healthy volunteers - a feasibility trialCritical Care, 2011
- Postconcussive symptoms in hospitalized pediatric patients after mild traumatic brain injuryJournal of Pediatric Surgery, 2009
- Intravascular cooling for rapid induction of moderate hypothermia in severely head-injured patients: results of a multicenter study (IntraCool)Intensive Care Medicine, 2008
- Noninvasive selective brain cooling by head and neck cooling is protective in severe traumatic brain injuryJournal of Clinical Neuroscience, 2006
- Does age play a role in recovery from sports-related concussion? A comparison of high school and collegiate athletesThe Journal of Pediatrics, 2003